57R-25416-38154
3 vaccinations
2 coded responses
37 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-16
Registered in v-safe
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-06-13
- 2021-09-12
-
2021-11-04
Dose 2 — ModernaCo-administered: Flu
- 2021-11-04
-
2021-11-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
-
2022-02-03
Survey response — 3 months, dose 2MedDRA: Fatigue, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion and fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-05
-
2022-10-14
Dose 3 — ModernaCo-administered: Flu
- 2022-10-20
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2023-01-14
-
2023-04-14
Survey response — 6 months, dose 3MedDRA: Cough, Mastitis, Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-14
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-04 | Moderna | Flu |
| 3 | 2022-10-14 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-14 | Unsuccessful |
Free text
Release 11 — 3 months, dose 2
Symptoms: Congestion and fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Mastitis | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release